How should the nurse researcher most accurately interpret a relative risk that is greater than 1.0?
a. There is no difference between the experimental and control group outcomes.
b. The risk of the event is reduced in experimental event rate (EER) compared with control event rate (CER).
c. The risk of an event is greater in EER compared with CER.
d. It is the difference in risk of outcome between patients who have had the event and those who have not.
ANS: C
Feedback
A This describes the state of a relative risk that is equal to 1.0.
B This describes the state of a relative risk that is less than 1.0.
C This describes the state of a relative risk that is greater than 1.0.
D This describes absolute risk reduction.
You might also like to view...
What data should a nurse analyze when deciding to refer a patient with a psychiatric disorder to community-based care? Select all that apply
a. Need for PRN medication b. Severity of the patient's illness c. Need for structured formal therapy d. Presence of suicidal or homicidal ideation e. Amount of supervision required by the patient
Darker-skinned individuals are less prone to the signs of aging because of:
1. Melanin. 2. Skin products used. 3. Dermabrasion. 4. Alopecia.
A healthcare provider giving medications must know the ________ for giving the drug
Fill in the blank(s) with correct word
The nurse in charge of a clinical study welcomes the participants in an open forum. One client is surprised that there are men and women from several ethnic groups. The nurse explains that in the past, ethnic variables were largely unknown or ignored for what reasons?Note: Credit will be given only if all correct choices and no incorrect choices are selected. Select all that apply.
A. Clinical trials failed to include ethnically diverse subjects. B. Clinical trials comprised mostly Caucasian males. C. Little attention was focused on identifying the different effects drugs had on various ethnic groups. D. Research proved there were no differences among ethnic groups. E. The large majority of clinical trials included Caucasian females.